Literature DB >> 11972509

Transfusion-associated graft-versus-host disease.

Marlis L Schroeder1.   

Abstract

Mesh：

Year:  2002        PMID： 11972509     DOI： 10.1046/j.1365-2141.2002.03450.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  20 in total

1.  Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.

Authors:  James Ferrara; Pavan Reddy; Sophie Paczesny
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Blood and blood component therapy in neonates.

Authors:  Richa Jain; Bipin Jose; Poonam Coshic; Ramesh Agarwal; Ashok K Deorari
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

3.  Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient.

Authors:  Ketan K Patel; Atul K Patel; Rajiv R Ranjan; Apurva P Shah
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-01       Impact factor: 0.900

4.  11 Adverse Reactions.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 5.  [Coagulopathy in multiple trauma: new aspects of therapy].

Authors:  O Grottke; D Henzler; D R Spahn; R Rossaint
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

6.  Transfusion-Associated Graft-Versus-Host Disease with a Non-fatal Course.

Authors:  Suruchi Gupta; Tushar Sehgal; Man Updesh Singh Sachdeva; Shano Naseem; Reena Das; Ritambhra Nada
Journal:  Indian J Hematol Blood Transfus       Date:  2016-04-12       Impact factor: 0.900

7.  Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution.

Authors:  Shelly M Williams; Darin Sumstad; Diane Kadidlo; Julie Curtsinger; Xianghua Luo; Jeffrey S Miller; David H McKenna
Journal:  Transfusion       Date:  2018-03-12       Impact factor: 3.157

8.  Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.

Authors:  Kivanc Serefhanoglu; Hale Turan; Tonguc Saba; Ismail Ozer; Emine Tosun; Hande Arslan
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

9.  The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells.

Authors:  Heather J Symons; Moshe Y Levy; Jie Wang; Xiaotao Zhou; Gang Zhou; Sarah E Cohen; Leo Luznik; Hyam I Levitsky; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

10.  Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.

Authors:  Girish T Nagendra; Ramakrishna M N; Devi Prasad Hegde; Sharad Damodar; Ratan Gupta
Journal:  Indian J Crit Care Med       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.